170 related articles for article (PubMed ID: 6282408)
1. Serum 1,25-dihydroxyvitamin D levels in subjects with X-linked hypophosphatemic rickets and osteomalacia.
Lyles KW; Clark AG; Drezner MK
Calcif Tissue Int; 1982 Mar; 34(2):125-30. PubMed ID: 6282408
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D metabolism in hypophosphatemic rickets.
Mason RS; Rohl PG; Lissner D; Posen S
Am J Dis Child; 1982 Oct; 136(10):909-13. PubMed ID: 6981996
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone effects on serum 1,25-dihydroxyvitamin D levels in patients with X-linked hypophosphatemic rickets: evidence for abnormal 25-hydroxyvitamin D-1-hydroxylase activity.
Lyles KW; Drezner MK
J Clin Endocrinol Metab; 1982 Mar; 54(3):638-44. PubMed ID: 6276432
[TBL] [Abstract][Full Text] [Related]
4. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia.
Yamazaki Y; Okazaki R; Shibata M; Hasegawa Y; Satoh K; Tajima T; Takeuchi Y; Fujita T; Nakahara K; Yamashita T; Fukumoto S
J Clin Endocrinol Metab; 2002 Nov; 87(11):4957-60. PubMed ID: 12414858
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
Drezner MK; Lyles KW; Haussler MR; Harrelson JM
J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
[TBL] [Abstract][Full Text] [Related]
6. Effect of single oral phosphate loading on vitamin D metabolites in normal subjects and in X-linked hypophosphatemic rickets.
Yamaoka K; Tanaka H; Kurose H; Shima M; Ozono K; Nakajima S; Seino Y
Bone Miner; 1989 Sep; 7(2):159-69. PubMed ID: 2804451
[TBL] [Abstract][Full Text] [Related]
7. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
Harrell RM; Lyles KW; Harrelson JM; Friedman NE; Drezner MK
J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in pediatric metabolic bone disease: the consequences of altered phosphate homeostasis in renal insufficiency and hypophosphatemic vitamin D-resistant rickets.
Pettifor JM
Bone Miner; 1990 Jun; 9(3):199-214. PubMed ID: 2163713
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of bone markers in hypophosphatemic rickets/osteomalacia.
Nagata Y; Imanishi Y; Ishii A; Kurajoh M; Motoyama K; Morioka T; Naka H; Mori K; Miki T; Emoto M; Inaba M
Endocrine; 2011 Oct; 40(2):315-7. PubMed ID: 21822687
[TBL] [Abstract][Full Text] [Related]
10. Hypophosphatemic rickets/osteomalacia in linear sebaceous nevus syndrome: a variant of tumor-induced osteomalacia.
Carey DE; Drezner MK; Hamdan JA; Mange M; Ahmad MS; Mubarak S; Nyhan WL
J Pediatr; 1986 Dec; 109(6):994-1000. PubMed ID: 3023599
[TBL] [Abstract][Full Text] [Related]
11. Levels and dynamic changes of serum fibroblast growth factor 23 in hypophosphatemic rickets/osteomalacia.
Xia WB; Jiang Y; Li M; Xing XP; Wang O; Hu YY; Zhang HB; Liu HC; Meng XW; Zhou XY
Chin Med J (Engl); 2010 May; 123(9):1158-62. PubMed ID: 20529556
[TBL] [Abstract][Full Text] [Related]
12. Decreased concentration of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with X-linked hypophosphatemic rickets: effect of phosphate supplementation.
Nakajima S; Yamaoka K; Yamamoto T; Okada S; Tanaka H; Seino Y
Bone Miner; 1990 Sep; 10(3):201-9. PubMed ID: 2171704
[TBL] [Abstract][Full Text] [Related]
13. 24,25 Dihydroxyvitamin D supplementation corrects hyperparathyroidism and improves skeletal abnormalities in X-linked hypophosphatemic rickets--a clinical research center study.
Carpenter TO; Keller M; Schwartz D; Mitnick M; Smith C; Ellison A; Carey D; Comite F; Horst R; Travers R; Glorieux FH; Gundberg CM; Poole AR; Insogna KL
J Clin Endocrinol Metab; 1996 Jun; 81(6):2381-8. PubMed ID: 8964881
[TBL] [Abstract][Full Text] [Related]
14. Serum 1,25-dihydroxyvitamin D concentration in hypophosphatemic vitamin D-resistant rickets.
Delvin EE; Glorieux FH
Calcif Tissue Int; 1981; 33(2):173-5. PubMed ID: 6260313
[TBL] [Abstract][Full Text] [Related]
15. Serum FGF23 levels in normal and disordered phosphorus homeostasis.
Weber TJ; Liu S; Indridason OS; Quarles LD
J Bone Miner Res; 2003 Jul; 18(7):1227-34. PubMed ID: 12854832
[TBL] [Abstract][Full Text] [Related]
16. X-linked hypophosphatemia: a clinical, biochemical, and histopathologic assessment of morbidity in adults.
Reid IR; Hardy DC; Murphy WA; Teitelbaum SL; Bergfeld MA; Whyte MP
Medicine (Baltimore); 1989 Nov; 68(6):336-52. PubMed ID: 2811660
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
Jonsson KB; Zahradnik R; Larsson T; White KE; Sugimoto T; Imanishi Y; Yamamoto T; Hampson G; Koshiyama H; Ljunggren O; Oba K; Yang IM; Miyauchi A; Econs MJ; Lavigne J; Jüppner H
N Engl J Med; 2003 Apr; 348(17):1656-63. PubMed ID: 12711740
[TBL] [Abstract][Full Text] [Related]
18. Clinical aspects of X-linked hypophosphatemic rickets.
Chung WT; Niu DM; Lin CY
Acta Paediatr Taiwan; 2002; 43(1):26-34. PubMed ID: 11890223
[TBL] [Abstract][Full Text] [Related]
19. Effect of dipyridamole on serum and urinary phosphate in X-linked hypophosphatemia.
Seikaly MG; Quigley R; Baum M
Pediatr Nephrol; 2000 Nov; 15(1-2):57-9. PubMed ID: 11095012
[TBL] [Abstract][Full Text] [Related]
20. Specific internalization and action of 1,25-dihydroxyvitamin D3 in cultured dermal fibroblasts from patients with X-linked hypophosphatemia.
Adams JS; Gacad MA; Singer FR
J Clin Endocrinol Metab; 1984 Sep; 59(3):556-60. PubMed ID: 6547728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
